L827-1812 Screening compound: 5-[3-(3-fluorophenyl)-1,2,4-oxadiazol-5-yl]-N-{3-[4-(2-fluorophenyl)piperazin-1-yl]propyl}pyridin-2-amine

L827-1812 Screening compound: 5-[3-(3-fluorophenyl)-1,2,4-oxadiazol-5-yl]-N-{3-[4-(2-fluorophenyl)piperazin-1-yl]propyl}pyridin-2-amine
L827-1812 Screening compound: 5-[3-(3-fluorophenyl)-1,2,4-oxadiazol-5-yl]-N-{3-[4-(2-fluorophenyl)piperazin-1-yl]propyl}pyridin-2-amine alternative view

Chemical Structure Depiction of ChemDiv screening compound L827-1812
5-[3-(3-fluorophenyl)-1,2,4-oxadiazol-5-yl]-N-{3-[4-(2-fluorophenyl)piperazin-1-yl]propyl}pyridin-2-amine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L827-1812

Molecular Formula

C26H26F2N6O (C26 H26 F2 N6 O)

Compound Name

5-[3-(3-fluorophenyl)-1,2,4-oxadiazol-5-yl]-N-{3-[4-(2-fluorophenyl)piperazin-1-yl]propyl}pyridin-2-amine

IUPAC name

5-[3-(3-fluorophenyl)-124-oxadiazol-5-yl]-N-{3-[4-(2-fluorophenyl)piperazin-1-yl]propyl}pyridin-2-amine

SMILES

Fc1cccc(-c2noc(-c(cc3)cnc3NCCCN(CC3)CCN3c(cccc3)c3F)n2)c1

InChI

InChI=1S/C26H26F2N6O/c27-21-6-3-5-19(17-21)25-31-26(35-32-25)20-9-10-24(30-18-20)29-11-4-12-33-13-15-34(16-14-33)23-8-2-1-7-22(23)28/h1-3,5-10,17-18H,4,11-16H2,(H,29,30)

InChI Key

OCTQUOUIIOYIFP-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27478389

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

476.53

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.339

Distribution Coefficient, logD

5.215

Water Solubility, LogSw

-5.59

Polar Surface Area

58.367

Acid Dissociation Constant (pKa)

21.00

Base Dissociation Constant (pKb)

6.92

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

26.90

L827-1812 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

C-Met Library (15277 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L827-1812 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L827-1812?
Check Price and Availability of L827-1812, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L827-1812 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L827-1812
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L827-1812
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L827-1812 available by request